Login    Join free Add to favorites    中文
home > news > APEIRON to Present at the Biotech Showcase™ Annual Conference
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
APEIRON to Present at the Biotech Showcase™ Annual Conference

hits:478     Date:01/08/18
APEIRON to Present at the Biotech Showcase™ Annual Conference on January 9, 2018
Vienna, Austria, January 5, 2018 鈥 APEIRON Biologics AG, a company focused on cancer immunotherapy, today announced that it will present at Biotech Showcase™ 2018, to be held January 8鈥10 at the Hilton San Francisco Union Square during one of the most important weeks in healthcare investing.
APEIRON Biologics AG will present at the Biotech Showcase™ as follows:
Date: Tuesday, January 9, 2018
Time: 1:45 p.m. (PST)
Room: Franciscan D, Ballroom Level
Venue: Hilton San Francisco Union Square Hotel, 333 O鈥橣arrell Street, San Francisco, CA (United States)
In San Francisco, management will conduct a large number of meetings with healthcare investors. If you would like to schedule a meeting, please feel free to reach out to one of the contacts listed at the end of this press release.
About APEIRON Biologics AG
APEIRON is a private biotech company based in Vienna, Austria, engaged in innovative projects in immuno-oncology. Recently, the most advanced program, an antibody-based immunotherapy to treat neuroblastoma, was granted marketing approval in the EU. The company is developing additional immunotherapies, predominantly in clinical stage, based either on targeted, tumor-specific approaches or on the stimulation of the immune system via novel and proprietary modes of action (unique checkpoint blockade mechanisms) to fight cancer by engaging the human body鈥檚 natural defense mechanisms. For additional information please go to www.apeiron-biologics.com and follow us on Twitter @apeironbio.
For further information please contact:
APEIRON Biologics AG
Peter Llewellyn-Davies, CFO/CBO
Related News>> more

Copyright(C) 2006-2018 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙